64 results
DEFR14A
ACET
Adicet Bio Inc
26 Apr 24
Revised proxy
4:13pm
affiliated with OrbiMed (1)
RA Capital Healthcare Fund, L.P. (2)
Tang Capital Partners, LP (3)
RTW Investments, LP (4)
Commodore Capital Master LP (5 … ) 6,138,000 shares of common stock held by RA Capital Healthcare Fund, L.P. (the Fund), (ii) 1,558,949 shares of common stock that the Fund beneficially owns
PRE 14A
ACET
Adicet Bio Inc
12 Apr 24
Preliminary proxy
5:23pm
Entities affiliated with OrbiMed (1)
RA Capital Healthcare Fund, L.P. (2)
Tang Capital Partners, LP (3)
RTW Investments, LP (4)
Commodore Capital Master LP … ) 6,138,000 shares of common stock held by RA Capital Healthcare Fund, L.P. (the Fund), (ii) 1,558,949 shares of common stock that the Fund beneficially owns
8-K
EX-1.1
ACET
Adicet Bio Inc
22 Mar 24
Entry into a Material Definitive Agreement
4:15pm
and Healthcare Products Regulatory Agency (the “MHRA”), the German Federal Institute for Drugs and Medical Devices (the “BfArM”), or any other federal, state
424B5
d3366cp
22 Mar 24
Prospectus supplement for primary offering
4:12pm
8-K
EX-1.1
ttg hq4e8v9
24 Jan 24
Adicet Bio, Inc. Announces Proposed Public Offering
4:34pm
424B5
7r5tkgxvxxm
24 Jan 24
Prospectus supplement for primary offering
4:32pm
424B5
f2nxc7k k3sa2p9yh
22 Jan 24
Prospectus supplement for primary offering
4:30pm
424B5
lgi g0nio994jzu4h4me
8 Nov 22
Prospectus supplement for primary offering
5:23pm
8-K
EX-1.1
e56e9
10 Dec 21
Adicet Bio, Inc. Announces Proposed Follow-On Offering of Common Stock
4:20pm
424B5
2awn7yix5t4ip
9 Dec 21
Prospectus supplement for primary offering
5:14pm